Market Closed -
Nasdaq
02:00:01 14/05/2024 am IST
5-day change
1st Jan Change
2.245
USD
+2.18%
+2.05%
+5.40%
NEXGEL, Inc. Provides Revenue Guidance for the First Quarter of 2023
April 01, 2024 at 05:20 pm IST
NEXGEL, Inc. provided revenue guidance for the first quarter of 2023. For the year, company expects revenue of $1.25 million.
Earnings Flash (NXGL) NEXGEL Reports Q1 Revenue $1.3M, vs. Street Est of $1.2M
14/05
MT
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
01/04
CI
Transcript : NEXGEL, Inc., Q4 2023 Earnings Call, Apr 01, 2024
01/04
Earnings Flash (NXGL) NEXGEL Posts Q4 Revenue $1.1M
01/04
MT
NEXGEL, Inc. Provides Revenue Guidance for the First Quarter of 2023
01/04
CI
NEXGEL, Inc. Announces Intention of Miranda J. Toledano to Resign as a Member of the Board of Directors, Effective as of March 31, 2024
17/01
CI
Top Premarket Decliners
16/01
MT
Nexgel Subsidiary, Cg Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
09/01
CI
NEXGEL, Inc. Announces Resignation of David Stefansky as Member of the Board of Directors
13/12
CI
Nexgel Enters Deal With Stada Arzneimittel to Distribute OTC Products Across North America
11/12
MT
NEXGEL, Inc. Announces Partnership with STADA Arzneimittel AG to Distribute and Commercialize Consumer Health OTC Products in North America
11/12
CI
NEXGEL, Inc. acquired Kenkoderm from Olympus Trading Company, LLC for $1.1 million.
05/12
CI
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022.
14/11
CI
NEXGEL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
14/11
CI
Transcript : NEXGEL, Inc., Q3 2023 Earnings Call, Nov 13, 2023
14/11
Earnings Flash (NXGL) NEXGEL Reports Q3 Revenue $1.2M, vs. Street Est of $1.2M
14/11
MT
Sector Update: Health Care Stocks Higher in Afternoon Trading
30/23/30
MT
NEXGEL Unit Executes Supply Agreement with AbbVie
30/23/30
MT
NEXGEL, Inc. Secures Supply Agreement with AbbVie Inc
30/23/30
CI
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022.
15/23/15
CI
NEXGEL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
15/23/15
CI
Transcript : NEXGEL, Inc., Q2 2023 Earnings Call, Aug 14, 2023
15/23/15
Earnings Flash (NXGL) NEXGEL Reports Q2 Revenue $1.2M, vs. Street Est of $1M
15/23/15
MT
NEXGEL Partners With Enigma Health for Retail Distribution, Marketing Services in North America
19/23/19
MT
Transcript : NEXGEL, Inc., Q1 2023 Earnings Call, May 15, 2023
16/23/16
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Companyâs converting and packaging business, which is based in Granbury, Texas. All of its gel products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty.
More about the company
Last Close Price
2.245
USD
Average target price
6
USD
Spread / Average Target
+167.26%
Consensus
1st Jan change
Capi.
+5.40% 13.68M +29.98% 684B +30.34% 568B -3.52% 361B +18.59% 329B +4.07% 284B +16.21% 240B +9.66% 208B -6.83% 200B +7.09% 166B
Other Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
NEXGEL, INC. 